Magenta Lifecare Limited IPO
The Company was initially incorporated as “Magenta Lifecare Private Limited” under the Companies Act, 2013, receiving its certificate of incorporation on August 04, 2015, from the Assistant Registrar of Companies, Gujarat. Following a special resolution by our shareholders on June 19, 2023, the company was converted into a public limited company and renamed “Magenta Lifecare Limited.” A fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad, on July 05, 2023.
Product Offerings
Magenta Lifecare Limited is a manufacturer of foam-based products, including mattresses and pillows, marketed under the brand “Magenta” in India. Their product range includes various types of mattresses such as memory foam, latex-based, bonded mattresses, and pocketed spring mattresses. Additionally, they offer pillows including memory foam pillows, molded memory foam pillows, and molded contour foam pillows. They pride themselves on the quality of their products, which serve customers across retail, hotels, and institutions.
Innovation and Product Development Driven by innovation, they continuously introduce new and innovative products. Their offerings include green tea and bamboo charcoal-based herbal mattresses and pet bed mattresses. They also supply processed raw foam and adjustable bed frames (hydraulic beds) under the Magenta brand. Their products cater to a broad segment of society, from value-added products to the premium segment, providing comfort, ergonomic design, thermal comfort, pressure relief, motion isolation, easy position realignment, and long-term durability.
Customization and Distribution They offer extensive customization options for mattresses in terms of fabric, shape, firmness, material, height, foam type & density, personalization, utility, and structure. Their well-developed distributor and dealer/retailer network spans multiple states in India. They sell their products through offline multi-brand outlets, a network of dealers, and online e-commerce platforms, with region-wise appointed distributors.
Vision and Mission They aim to provide high-quality, innovative foam-based products that enhance comfort and sleep quality for their customers. Their mission is to support, comfort, and cool the body, leading to better-quality sleep with products designed for long-term durability and ergonomic benefits.
Objects of the Magenta Lifecare Limited IPO:
Magenta Lifecare Limited IPO Details:
Open Date: | Jun 05 2024 |
Close Date: | Jun 07 2024 |
Total Shares: | 2,000,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Size: | 7.00 Cr. |
Lot Size: | 4000 Shares |
Issue Price: | ₹ 35 Per Equity Share |
Listing At: | BSE SME |
Listing Date: | Jun 12 2024 |
Promoters And Management:
Financials of Magenta Lifecare Limited IPO:
Particulars ( In Lakhs ) |
2021 |
2022 |
2023 |
9M-FY24 |
Revenue from Operations | 965 | 924 | 907 | 602 |
Other Income | 1 | 14 | 49 | 29 |
Total Revenue | 966 | 938 | 955 | 631 |
Cost Raw Material Consumed | 716 | 658 | 601 | 393 |
Employees Benefit Expenses | 55 | 69 | 77 | 55 |
Other Expenses | 89 | 91 | 141 | 59 |
EBITDA | 106 | 120 | 136 | 124 |
OPM (%) | 10.96% | 12.83% | 14.22% | 19.68% |
Depreciation & Amortisation | 20 | 20 | 20 | 15 |
EBIT | 86 | 100 | 116 | 109 |
Finance Cost | 68 | 77 | 84 | 42 |
PBT | 18 | 23 | 32 | 66 |
Tax | -2 | 4 | 7 | 42 |
PAT | 19 | 19 | 25 | 24 |
NPM (%) | 2.01% | 2.01% | 2.57% | 3.86% |
No.of Shares | 68.69 | 68.69 | 68.69 | 68.69 |
EPS | 0.28 | 0.27 | 0.35 | 0.35 |
Comparison With Peers:
Name of the Company | Revenue (In Crore) | PAT (In Crore) | EPS ( in Rs) | P/E | CMP | Mcap (In Crore) |
Magenta Lifecare Limited | 9 | 0.2 | 0.35 | 97.9 | 35 | 24 |
Sheela Foam Limited | 2,873 | 203 | 20.62 | 58.8 | 894 | 9,716 |
Tirupati Foam Limited | 102 | 2 | 4.31 | 15.6 | 74.3 | 33 |
Recommendation on Magenta Lifecare Limited IPO:
Lead Manager of Magenta Lifecare Limited IPO:
Registrar of Magenta Lifecare Limited IPO:
Company Address:
Discussion on Magenta Lifecare Limited IPO:
Leave a Reply
You must be logged in to post a comment.